Evidence map›Paper›PMID 39273354›Full record

ReviewInternational journal of molecular sciences2024

Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness.

Carmine Secondulfo, Filomena Mazzeo, Grazia Maria Giovanna Pastorino, Antonella Vicidomini, Rosaria Meccariello, Francesca Felicia Operto

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Chronic Pain and Opioids in the Elderly: Treating the Brain, Not Just the Body.International journal of environmental research and public health · 2026
    Review
  3. Article
  4. Review
  5. Chemometric Optimization of BFChemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carmine SecondulfoDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.ORCID 0000-0003-2742-237X
Filomena MazzeoDepartment of Economics, Law, Cybersecurity and Sports Sciences, University of Naples Parthenope, 80035 Nola, Italy.ORCID 0000-0002-5217-4710
Grazia Maria Giovanna PastorinoDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.ORCID 0000-0003-0404-5495
Antonella VicidominiDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.
Rosaria MeccarielloDepartment of Medical, Human Movement and Well-Being Sciences, University of Naples Parthenope, 80133 Naples, Italy.ORCID 0000-0003-2174-1118
Francesca Felicia OpertoDepartment of Science of Health, School of Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-2444-8761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain is an unpleasant sensory and emotional experience. Adequate pain control is often challenging, particularly in patients with chronic pain. Despite advances in pain management, drug addiction, overtreatment, or substance use disorders are not rare. Hence the need for further studies in the field. The substantial progress made over the last decade has revealed genes, signalling pathways, molecules, and neuronal networks in pain control thus opening new clinical perspectives in pain management. In this respect, data on the epigenetic modulation of opioid and cannabinoid receptors, key actors in the modulation of pain, offered new perspectives to preserve the activity of opioid and endocannabinoid systems to increase the analgesic efficacy of opioid- and cannabinoid-based drugs. Similarly, upcoming data on cannabidiol (CBD), a non-psychoactive cannabinoid in the marijuana plant

Indexed as

Analgesics, OpioidCannabinoidsReceptors, CannabinoidAnimalsCannabidiolChronic PainEndocannabinoidsEpigenesis, GeneticHumansPainPain ManagementReceptors, OpioidAnalgesics, OpioidCannabidiolCannabinoidsEndocannabinoidsReceptors, CannabinoidReceptors, OpioidcannabinoidsCB1CBDclinical practiceepigeneticshealth and fitnessopioidsOprm1pain

Identifiers

PMID39273354
PMCPMC11394805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.